Literature DB >> 20664628

Chronic kidney disease: Absence of evidence or evidence of absence? ACS treatment in CKD.

Dena E Rifkin, Mark J Sarnak.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20664628     DOI： 10.1038/nrneph.2010.82

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  9 in total

Review 1.  Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease.

Authors:  Steven G Coca; Harlan M Krumholz; Amit X Garg; Chirag R Parikh
Journal:  JAMA       Date:  2006-09-20       Impact factor: 56.272

2.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

Authors:  Christoph Wanner; Vera Krane; Winfried März; Manfred Olschewski; Johannes F E Mann; Günther Ruf; Eberhard Ritz
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

3.  "Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency.

Authors:  Glenn M Chertow; Sharon-Lise T Normand; Barbara J McNeil
Journal:  J Am Soc Nephrol       Date:  2004-09       Impact factor: 10.121

4.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

5.  Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.

Authors:  Nagesh S Anavekar; John J V McMurray; Eric J Velazquez; Scott D Solomon; Lars Kober; Jean-Lucien Rouleau; Harvey D White; Rolf Nordlander; Aldo Maggioni; Kenneth Dickstein; Steven Zelenkofske; Jeffrey D Leimberger; Robert M Califf; Marc A Pfeffer
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

6.  Associations of kidney function with cardiovascular medication use after myocardial infarction.

Authors:  Wolfgang C Winkelmayer; Raisa Levin; Soko Setoguchi
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-09       Impact factor: 8.237

7.  Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients.

Authors:  Michael G Shlipak; Paul A Heidenreich; Haruko Noguchi; Glenn M Chertow; Warren S Browner; Mark B McClellan
Journal:  Ann Intern Med       Date:  2002-10-01       Impact factor: 25.391

8.  Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry.

Authors:  Caroline S Fox; Paul Muntner; Anita Y Chen; Karen P Alexander; Matthew T Roe; Christopher P Cannon; Jorge F Saucedo; Michael C Kontos; Stephen D Wiviott
Journal:  Circulation       Date:  2010-01-11       Impact factor: 29.690

9.  Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Authors:  Bengt C Fellström; Alan G Jardine; Roland E Schmieder; Hallvard Holdaas; Kym Bannister; Jaap Beutler; Dong-Wan Chae; Alejandro Chevaile; Stuart M Cobbe; Carola Grönhagen-Riska; José J De Lima; Robert Lins; Gert Mayer; Alan W McMahon; Hans-Henrik Parving; Giuseppe Remuzzi; Ola Samuelsson; Sandor Sonkodi; D Sci; Gultekin Süleymanlar; Dimitrios Tsakiris; Vladimir Tesar; Vasil Todorov; Andrzej Wiecek; Rudolf P Wüthrich; Mattis Gottlow; Eva Johnsson; Faiez Zannad
Journal:  N Engl J Med       Date:  2009-03-30       Impact factor: 91.245
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.